Shuttle Pharmaceuticals Holdings, Inc.
Data quality: 83%
SHPH
Nasdaq
Manufacturing
Chemicals
$0.73
▼
$0.03
(-3.33%)
Mkt Cap: 4.05 M
Price
$0.73
Mkt Cap
4.05 M
Day Range
$0.70 — $0.73
52-Week Range
$0.50 — $12.45
Volume
33,713
Open $0.70
50D / 200D Avg
$1.19
38.84% below
50D / 200D Avg
$2.58
71.93% below
Quick Summary
Key Takeaways
Negative free cash flow of -9.48 M
Growth
Revenue Growth (5Y)
N/A
Revenue (1Y)N/A
Earnings (1Y)N/A
FCF Growth (3Y)N/A
Quality
Return on Equity
-468.90%
Below sector avg (-51.02%)
ROIC-349.35%
Net MarginN/A
Op. MarginN/A
Safety
Debt / Equity
N/A
Current Ratio1.66
Interest CoverageN/A
Valuation
PE (TTM)
-0.35
Above sector avg (-1.98)
P/B Ratio2.91
EV/EBITDAN/A
Dividend YieldN/A
Price History
Financial Trends
Peer Comparison
vs Manufacturing sector median (44 peers)
Peer Comparison
vs Manufacturing sector median (44 peers)| Metric | Stock | Sector Median |
|---|---|---|
| P/E | -0.4 | -2.0 |
| P/B | 2.9 | 5.1 |
| ROE % | -468.9 | -51.0 |
| Net Margin % | — | -150.2 |
| Rev Growth 5Y % | — | 9.3 |
| D/E | — | 0.3 |
All Fundamental Metrics
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | N/A | Revenue Growth (3Y) | N/A |
| Earnings Growth (1Y) | N/A | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | N/A | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | N/A | Net Income (TTM) | -11.72 M |
| ROE | -468.90% | ROA | -259.12% |
| Gross Margin | N/A | Operating Margin | N/A |
| Net Margin | N/A | Free Cash Flow (TTM) | -9.48 M |
| ROIC | -349.35% | FCF Growth (3Y) | N/A |
| Safety | |||
| Debt / Equity | N/A | Current Ratio | 1.66 |
| Interest Coverage | N/A | Asset Turnover | N/A |
| Working Capital | 1.30 M | Tangible Book Value | 1.39 M |
| Dividends | |||
| Dividend Yield | N/A | Payout Ratio | N/A |
| Dividend Growth (3Y) | N/A | Dividend Growth (5Y) | N/A |
| Consecutive Div Years | N/A | ||
| Valuation | |||
| P/E Ratio | -0.35 | Forward P/E | N/A |
| P/B Ratio | 2.91 | P/S Ratio | N/A |
| PEG Ratio | N/A | Forward PEG | N/A |
| EV/EBITDA | N/A | Fwd EV/EBITDA | N/A |
| Forward P/S | N/A | Fwd Earnings Yield | N/A |
| FCF Yield | -233.87% | ||
| Market Cap | 4.05 M | Enterprise Value | 1.96 M |
| Per Share | |||
| EPS (Diluted TTM) | -7.16 | Revenue / Share | N/A |
| FCF / Share | -1.70 | OCF / Share | -1.70 |
| EPS CAGR (1Y) | N/A | EPS CAGR (5Y) | N/A |
| EPS CAGR (10Y) | N/A | ||
| Efficiency | |||
| CapEx / Revenue | N/A | FCF Conversion | 80.89% |
| SBC-Adj. FCF | -10.27 M | Growth Momentum | N/A |
Income Statement
Annual, most recent first
Income Statement
Annual, most recent first| Metric | FY2025 | FY2024 | FY2023 | FY2022 |
|---|---|---|---|---|
| Revenue | — | — | — | — |
| Net Income | -11.72 M | -9.14 M | -6.59 M | -3.03 M |
| EPS (Diluted) | -7.16 | -3.30 | -0.44 | — |
| Gross Profit | — | — | — | — |
| Operating Income | -11.92 M | -7.70 M | -5.89 M | -2.55 M |
| EBITDA | — | — | — | — |
| R&D Expenses | 4.05 M | 3.62 M | 3.52 M | 1.49 M |
| SG&A Expenses | — | — | — | — |
| D&A | 290,107.0 | — | — | — |
| Interest Expense | — | 100,000.0 | 2.12 M | 917,879.0 |
| Income Tax | — | — | — | — |
Balance Sheet
Annual, most recent first
Balance Sheet
Annual, most recent first| Metric | FY2025 | FY2024 | FY2023 | FY2022 |
|---|---|---|---|---|
| Total Assets | 10.48 M | 2.51 M | 5.95 M | 8.65 M |
| Total Liabilities | 8.22 M | 1.80 M | 1.90 M | 975,676.0 |
| Shareholders' Equity | 2.25 M | 709,152.0 | 4.06 M | 7.68 M |
| Total Debt | — | — | — | 91,021.0 |
| Cash & Equivalents | 334,005.0 | 1.92 M | 2.58 M | 8.42 M |
| Current Assets | 502,911.0 | 2.21 M | 5.59 M | 8.58 M |
| Current Liabilities | 7.97 M | 1.53 M | 1.04 M | 975,676.0 |
{"event":"ticker_viewed","properties":{"ticker":"SHPH","listing_kind":"stock","pathname":"/stocks/shph","exchange":"Nasdaq","country":"US"}}